SCHEDULE: Millennium Management Discloses 5% Stake in Omnicell

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, reported a 5.0% beneficial ownership stake in Omnicell, Inc. common stock.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander are the reporting persons.
• The filing pertains to Omnicell, Inc.'s Common Stock, par value $0.001 per share, with CUSIP Number 68213N109.
• The reporting persons collectively beneficially own 2,288,570 shares of Omnicell, Inc. common stock.
• This aggregate amount represents 5.0% of the class of Omnicell, Inc.'s common stock.
• The reporting persons have shared voting power and shared dispositive power over all 2,288,570 shares.
• The event requiring this filing occurred on March 25, 2026.
• The filing was made pursuant to Rule 13d-1(b) of the Securities Exchange Act of 1934.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant stake by a reputable institutional investor like Millennium Management can imply a belief in the issuer's value or future prospects, though it's purely an ownership disclosure.

Positives

• A significant institutional investor, Millennium Management LLC, has taken a 5.0% stake in Omnicell, Inc., potentially signaling confidence in the company's future prospects.

Negatives

• No specific negative information regarding Omnicell, Inc. is disclosed in this ownership filing.

Risks

• No specific risks related to Omnicell, Inc. are detailed in this Schedule 13G filing.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Omnicell, Inc.'s future outlook.

Management Comments

• The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC).

Industry Context

StockSavvy.ai notes that Millennium Management LLC is a well-known multi-strategy hedge fund. Their disclosure of a 5.0% stake in Omnicell, a healthcare technology company, indicates a significant institutional position, which could be interpreted by the market as a positive signal or a strategic investment in the healthcare automation sector.

Comparison to Industry Standards

• This filing is an ownership disclosure and does not provide performance metrics for comparison to industry standards.

Legal Proceedings

• No legal proceedings are disclosed in this Schedule 13G filing.

Related Party Transactions

• No related party transactions are disclosed in this Schedule 13G filing.

Stakeholder Impact

• Shareholders: May view the significant institutional investment as a positive indicator of confidence in Omnicell's stock.

Next Steps

• No specific future actions or milestones for Omnicell, Inc. are mentioned in this ownership filing.

Key Dates

Recommendation

The filing indicates a significant institutional investor, Millennium Management LLC, has taken a 5.0% stake in Omnicell, Inc. While this is a notable vote of confidence, the Schedule 13G itself does not provide fundamental financial or operational data to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and conduct further due diligence on Omnicell's business performance and market position, considering this new institutional interest as a potential positive factor.

Keywords

Omnicell, OMCL, Millennium Management, Israel Englander, Schedule 13G, beneficial ownership, institutional investment, common stock, healthcare technology